Proteolipid Protein 1 (PLP1) Peptid
PLP1
Reaktivität: Säugetier
Wirt: Synthetic
BP, WB, IHC
-
- Target Alle PLP1 Produkte
- PLP1 (Proteolipid Protein 1 (PLP1))
- Protein-Typ
- Synthetic
- Spezies
- Säugetier
-
Quelle
- Synthetic
- Applikation
- Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
- Sequenz
- GHEALTGTEK LIETYFSKNY QDYEYLINVI HAFQYVIYGT ASFFFLYGAL
- Produktmerkmale
-
A synthetic peptide for use as a blocking control in assays to test for specificity of PLP1 antibody,
Alternative Names: PLP1 control peptide, PLP1 antibody Blocking Peptide, Anti-PLP1 Blocking Peptide, Proteolipid Protein 1 Blocking Peptide, Pelizaeus-Merzbacher Disease Spastic Paraplegia 2 Uncomplicated Blocking Peptide, MMPL Blocking Peptide, PLP Blocking Peptide, PLP/DM20 Blocking Peptide, PMD Blocking Peptide, SPG2 Blocking Peptide, PLP1, PLP-1, PLP 1, PLP-1 Blocking Peptide, PLP 1 Blocking Peptide
-
-
- Applikationshinweise
- Optimal conditions should be determined by the investigator
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Rekonstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
- Buffer
- PBS
- Handhabung
- Avoid repeated freeze/thaw cycles.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Store at -20 °C long term.
-
- Target
- PLP1 (Proteolipid Protein 1 (PLP1))
- Hintergrund
- PLP1 is a transmembrane proteolipid protein that is the predominant myelin protein present in the central nervous system. It may play a role in the compaction, stabilization, and maintenance of myelin sheaths, as well as in oligodendrocyte development and axonal survival. Mutations in this gene cause X-linked Pelizaeus-Merzbacher disease and spastic paraplegia type 2. Alternatively spliced transcript variants encoding distinct isoforms or having different 5' UTRs, have been identified for this gene.
- Molekulargewicht
- 30 kDa
-
Sie sind hier:
